Latest Breaking News On - Its proprietary fast dissolving - Page 1 : comparemela.com

DGAP-News: XPhyto Therapeutics Corp. / Key word(s): Miscellaneous XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips 15.12.2021 / 09:05 The issuer is solely responsible for the content of this announcement. XPhyto Epilep.

United statesBaden wübergBritish columbiaHugh rogersKnox hendersonDistribution servicesClinical research centerXphyto therapeutics corpGlobal market insights incProduct developmentTransparency market researchEuropean medicines agencyUs food drug administrationCompany epilepsyTherapeutics corpEpilepsy clinical trial planned